Skadden, Arps, Slate, Meagher & Flom LLP and Affiliates

Valeant Proposes to Combine With Allergan

Skadden is advising Valeant Pharmaceuticals International, Inc. in its $46 billion proposed merger with Allergan, Inc., announced April 22.

BACK TO TOP